MF
DTIL icon

Manchester Financial’s Precision BioSciences DTIL Stock Holding History

Manchester Financial’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18
Closed -$6K – 229
2021
Q1 		$6K Hold
18
– – ﹤0.01% 505
2020
Q4 		$5K Hold
18
– – ﹤0.01% 455
2020
Q3 		$3K Hold
18
– – ﹤0.01% 450
2020
Q2 		$5K Buy
18
+11
+157% +$2.41K ﹤0.01% 376
2020
Q1 		$1K Hold
7
– – ﹤0.01% 457
2019
Q4 		$3K Buy
+7
New +$2.2K ﹤0.01% 468

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Manchester Financial's DTIL Position: Q2 2021 in Review

Manchester Financial sold out of Precision BioSciences (DTIL) in Q2 2021, closing a stake of 18 shares — an estimated $6K sold.

Manchester Financial first reported a position in DTIL in Q4 2019 and held it in 6 quarters. The position peaked at $6K in Q1 2021. 130 funds tracked by Wall St. Rank hold DTIL as of Q2 2021.

  • Manchester Financial reported no remaining Precision BioSciences position as of Q2 2021 after selling out during the quarter.
  • Manchester Financial sold 18 Precision BioSciences shares in Q2 2021, an estimated $6K.
  • Manchester Financial first reported a position in Precision BioSciences in Q4 2019 and held it in 6 quarters.
  • Manchester Financial's Precision BioSciences position peaked at $6K in Q1 2021.
  • 130 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.